Drug (as an intervention type)
A medicine — a chemical or small-molecule treatment — given as the thing being studied.
What it means
When a trial lists an intervention of type "Drug", the study is giving people a medicine and observing what happens. It may be a new medicine, an approved medicine used a new way, or a known medicine at a new dose. The name shown is the registry's own name for it.
Why it matters if you take part
The type tells you the general shape of what taking part involves — a medicine, not a device or a programme — and where to look for details: dosing, how it is given, and how long, are in the registry description and the consent process.
What it looks like in practice
Registry names can be code names (e.g. "ABC-123") for medicines that do not have a public name yet. That is normal for early-phase research.
Related terms
This explains how clinical research works. It is not medical advice and does not describe any specific condition or treatment. Only a trial site can determine whether someone can take part in a study.